Yahoo · Oct 15, 2026
Procter & Gamble Pre-Q1 Earnings: Is It Wise to Buy the Stock Now?
Procter & Gamble's Q1 earnings outlook signals modest sales growth but profit pressures from rising costs.
NASDAQ · PG
The Procter & Gamble Company
Consumer Defensive · Household & Personal Products
$156.53
Up+$0.53 (+0.34%)
Updated Oct 15, 2026, 11:03 PM
SID Score
7.7/10
Composite research score
Smart Money
49/100
Neutral
- Market cap
- 328.87B
- P/E ratio
- 20.46
- Dividend yield
- 2.67%
- 52-week range
- $137.62 – $167.25
- Volume
- 10.68M
- Avg. volume
- 8.54M
Price performance · PG
PG price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
PG closed at $156.53 after 21 trading sessions, up 6.47% for the selected period.
- Last close
- $156.53
- Period change
- +6.47%
- Period low
- $143.95
- Period high
- $156.53
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $154.64 | $156.63 | $154.285 | $156.53 | 10.68M |
| Oct 13, 2026 | $154.51 | $154.75 | $152.22 | $153.04 | 6.04M |
| Oct 12, 2026 | $151.25 | $153.25 | $150.95 | $153.20 | 6.22M |
| Oct 9, 2026 | $150.57 | $151.60 | $149.92 | $151.23 | 6.31M |
| Oct 8, 2026 | $147.74 | $150.76 | $147.05 | $150.59 | 12.05M |
| Oct 7, 2026 | $148.68 | $149.665 | $147.755 | $147.82 | 8.68M |
| Oct 6, 2026 | $148.02 | $149.68 | $147.06 | $148.41 | 13.33M |
| Oct 5, 2026 | $145.00 | $146.09 | $144.38 | $145.94 | 7.04M |
| Oct 2, 2026 | $144.40 | $145.21 | $143.81 | $144.91 | 6.25M |
| Oct 1, 2026 | $144.55 | $145.00 | $143.40 | $143.95 | 7.32M |
| Sep 30, 2026 | $148.90 | $149.23 | $145.28 | $145.28 | 8.58M |
| Sep 29, 2026 | $147.95 | $148.84 | $146.84 | $148.32 | 7.67M |
| Sep 28, 2026 | $145.86 | $149.48 | $145.11 | $149.03 | 8.85M |
| Sep 25, 2026 | $145.97 | $146.40 | $145.33 | $146.23 | 5.79M |
| Sep 24, 2026 | $147.74 | $149.20 | $145.68 | $145.68 | 7.43M |
| Sep 23, 2026 | $147.87 | $148.93 | $147.14 | $147.39 | 6.58M |
| Sep 22, 2026 | $147.42 | $148.25 | $146.95 | $148.22 | 5.64M |
| Sep 21, 2026 | $146.49 | $146.805 | $145.63 | $146.08 | 5.83M |
| Sep 18, 2026 | $146.44 | $146.70 | $145.49 | $146.39 | 12.94M |
| Sep 17, 2026 | $147.59 | $147.78 | $146.35 | $147.55 | 6.74M |
| Sep 16, 2026 | $146.83 | $148.23 | $146.50 | $147.02 | 6.95M |
Latest PG news
The latest Smart Investors Daily articles mentioning PG.
Stock researchCompany · Overview
Company
Market Activity
Research & News
PG research
Overview
Company profile and research snapshot.
Company profile
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $167.33
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 14, 2026 | Citigroup | Buy | — |
| Oct 6, 2026 | Evercore ISI Group | Outperform | — |
| Oct 6, 2026 | RBC Capital | Outperform | — |
| Sep 30, 2026 | TD Cowen | Hold | — |
| Aug 7, 2026 | Argus Research | Hold | — |
News briefing
Generated Oct 15, 2026, 7:15 PM
Why Is PG Up Today? Analyst Upgrade and Dividend Confidence Drive Modest Gains
Procter & Gamble edged up 0.30% today as positive analyst sentiment and reasserted dividend commitment provided modest support to the stock. The modest gains reflect a balanced market view on PG's valuation, dividend strategy, and product innovation initiatives amid mixed signals about fair pricing.
Bottom line: PG's modest gains today reflect a 'prove it' moment for the consumer staples giant: while analyst support and dividend confidence remain intact, valuation concerns and broader sector headwinds create meaningful ambiguity. Investors should monitor whether new product innovations and premium offerings can justify current valuations while cash flows remain sufficient to support long-term dividend growth.
Yahoo · Oct 15, 2026
Earnings Preview: Procter & Gamble (PG) Q1 Earnings Expected to Decline
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · Oct 15, 2026
Head & Shoulders Launches All-New Scalp Care Collection to Prove Healthier Hair Starts at the Scalp
CINCINNATI, October 15, 2026--Head & Shoulders today unveiled its new Scalp Care Collection, a line of skincare-inspired shampoos, conditioners and treatments built to care for the scalp while delivering the hair benefits people desire most. The collection features three personalized regimens designed for specific scalp needs that are clinically proven to remove visible flakes at the source and repair the scalp barrier for healthier-looking hair, bringing a new level of beauty to a brand best kn
Yahoo · Oct 14, 2026
Is Procter & Gamble Stock Priced Right Against Its Peers?
Procter & Gamble (PG) operates with a wider operating margin than its four rivals in household and personal care: Colgate-Palmolive, Church & Dwight, Estee Lauder and Kenvue. Over the past year, however, P&G stock returned the least of the five. Investors currently pay less for its earnings than they do for Church & Dwight's. So how much less are you paying, and for how much more profit.
AI research layers
Interpretive context generated from the platform’s current data sources.
Procter & Gamble Stock Performance
Procter & Gamble shares closed at $156.57, reflecting a modest daily gain of 0.09%, per SID market data. Over the trailing one-month period, the stock has advanced 4.73%, while the three-month return stands at 3.37% and the one-year return at 5.73%. PG currently trades above both its 50-day moving average of $146.25 and its 200-day moving average of $149.52, indicating sustained upward momentum according to Massive/Polygon technical data. The 14-day relative strength index reads 63.6, positioning the stock in neutral-to-moderately bullish territory without entering overbought conditions. Average daily trading volume is approximately 8.54 million shares, supporting adequate liquidity for institutional participants. The stock's beta of 0.382 underscores its defensive characteristics, exhibiting significantly lower volatility than the broader market. Procter & Gamble's market capitalization stands at approximately $328.9 billion, reinforcing its status as a mega-cap consumer staples leader.
Procter & Gamble Valuation Analysis
Procter & Gamble currently trades at a price-to-earnings ratio of 20.46, reflecting a premium consistent with the Consumer Defensive sector's stability and cash flow predictability, per SID market data. The PEG ratio of 3.90 suggests that the stock's valuation is elevated relative to its expected earnings growth rate, indicating limited growth-adjusted value at current price levels. The price-to-book ratio stands at 6.44, according to SEC filings, which reflects the company's significant intangible asset base including globally recognized brand portfolios. PG offers a dividend yield of approximately 2.97%, maintaining its longstanding status as a Dividend Aristocrat with decades of consecutive annual increases. The company's valuation metrics collectively indicate that investors are paying a premium for earnings visibility, defensive positioning, and reliable dividend income. At a market capitalization of $328.9 billion, PG remains one of the most richly valued names in the consumer staples space.
Smart Money Activity for PG
Procter & Gamble's composite smart money score stands at 49 out of 100, generating a neutral signal per SID market data. The institutional component scores a perfect 25 out of 25, reflecting robust and sustained interest from large asset managers and pension funds, according to 13F institutional filings. In contrast, the insider trading component registers 0 out of 25, despite notable recent activity — SEC Form 4 filings reveal 20 insider transactions over the past 90 days, comprising 17 purchases and only 3 sales. This 5.7-to-1 buy-to-sell ratio among corporate insiders suggests internal confidence in the company's forward trajectory. The dark pool activity score of 9.4 out of 25 indicates moderate off-exchange institutional positioning. Congressional trading activity scores 14.8 out of 25, reflecting middling legislative interest. The divergence between maximum institutional conviction and the low composite insider score warrants monitoring, as the high frequency of insider purchases may not yet be fully reflected in the aggregate scoring methodology.
Procter & Gamble Earnings Outlook
Procter & Gamble has demonstrated consistent earnings execution in recent quarters, per company earnings reports. In the most recently reported quarter ending April 2026, the company posted earnings per share of $1.59, exceeding analyst estimates of $1.56 by $0.03. The prior quarter delivered EPS of $1.43 against a consensus estimate of $1.42, representing a $0.01 positive surprise. Both quarters reflect PG's pattern of modest but reliable beats. Looking ahead, analysts project EPS of $1.42 for the July 2026 reporting period, with results expected on July 28. The subsequent quarter carries an earnings estimate of $1.89, with results anticipated on October 22, 2026, according to analyst estimates. The upward trajectory from $1.42 to $1.89 in sequential quarterly estimates suggests that the Street anticipates meaningful earnings acceleration in the fiscal period ahead, potentially driven by pricing actions and volume stabilization across key product categories.
Wall Street Analyst Ratings for PG
Recent Wall Street analyst activity on Procter & Gamble reflects a mixed but incrementally constructive outlook, per SID consensus data. On October 6, 2026, Evercore ISI Group upgraded PG to Outperform from In-Line, signaling renewed confidence in the company's growth prospects. On the same date, RBC Capital maintained its Outperform rating, reinforcing positive sentiment among large sell-side firms. Conversely, Argus Research downgraded the stock to Hold from Buy on August 7, 2026, citing valuation considerations according to Wall Street analyst reports. TD Cowen reiterated a Hold rating on September 30, 2026, maintaining a neutral stance. Citigroup maintained its Buy rating on July 30, 2026, following the company's earnings release. The distribution of recent ratings shows two firms at Outperform or Buy, two at Hold, and no Sell recommendations, suggesting that the consensus leans cautiously positive while acknowledging that PG's premium valuation limits near-term upside potential for new positions.
